Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subclinical CVD in Psoriatic Disease
NCT03228017Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Aug 2017
- Primary completion
- Apr 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label trial of aspirin and atorvastatin in cardiovascular disease (CVD) and thrombosis (2 arms), sponsored by NYU Langone Health. Primary endpoint: Mean Fold Change in Brachial Vein Endothelial Inflammatory Transcript at 5 Months. Started Aug 2017; status: completed.
02
Drugs
aspirinatorvastatin
03
Conditions
cardiovascular disease (CVD)thrombosis
Beyond the preview
Go deeper on NCT03228017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03228017.